We are live on ! Find out more
GGHC

Gilder Gagnon Howe & Co Portfolio holdings

AUM $8.34B
1-Year Est. Return 46.58%
This Fund
S&P 500
This Quarter Est. Return
+8.45%
1 Year Est. Return
+46.58%
3 Year Est. Return
+191.6%
5 Year Est. Return
+200.35%
10 Year Est. Return
+3,561.44%
AUM
$7.61B
AUM Growth
+$416M
Cap. Flow
+$124M
Cap. Flow %
1.62%
Top 10 Hldgs %
34.83%
Holding
318
New
52
Increased
54
Reduced
160
Closed
42

Top Buys

Rank Stock Value
1
EPAM icon
EPAM Systems
EPAM
+$106M
2
SAGE
Sage Therapeutics
SAGE
+$59.7M
3
ILMN icon
Illumina
ILMN
+$59.2M
4
SHOP icon
Shopify
SHOP
+$48.8M
5
AAL icon
American Airlines Group
AAL
+$45.9M

Sector Composition

Rank Sector Weight
1 Healthcare 22.29%
2 Consumer Discretionary 17.31%
3 Technology 17.16%
4 Communication Services 15.14%
5 Industrials 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VCYT icon
201
Veracyte
VCYT
$4.45B
$1.41M 0.02%
126,852
-2,774
-2% -$27.3K
SCMP
202
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
$1.39M 0.02%
84,830
+147
+0.2% +$2.55K
PDFS icon
203
PDF Solutions
PDFS
$1.72B
$1.39M 0.02%
86,587
+58
+0.1% +$997
TWC
204
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
$1.34M 0.02%
7,517
+1,040
+16% +$172K
KR icon
205
Kroger
KR
$36.7B
$1.33M 0.02%
36,826
-108
-0.3% -$3.93K
WING icon
206
Wingstop
WING
$3.8B
$1.33M 0.02%
+47,021
New +$1.36M
NVAX icon
207
Novavax
NVAX
$1.21B
$1.2M 0.02%
5,385
-91
-2% -$16K
TRUE
208
DELISTED
TrueCar
TRUE
$1.2M 0.02%
100,040
+2,662
+3% +$38.3K
ASMB icon
209
Assembly Biosciences
ASMB
$498M
$1.19M 0.02%
+5,135
New +$991K
CYBR
210
DELISTED
CyberArk
CYBR
$1.15M 0.02%
18,260
-519
-3% -$33.2K
PBH icon
211
Prestige Consumer Healthcare
PBH
$2.47B
$1.13M 0.01%
24,371
+2,170
+10% +$95K
INSG icon
212
Inseego
INSG
$104M
$1.02M 0.01%
+31,498
New +$1.52M
NVRO
213
DELISTED
NEVRO CORP.
NVRO
$890K 0.01%
16,567
-6,837
-29% -$348K
QUNR
214
DELISTED
Qunar Cayman Islands Limited
QUNR
$872K 0.01%
20,357
-2,841
-12% -$133K
NXPI icon
215
NXP Semiconductors
NXPI
$60.8B
$844K 0.01%
8,594
+5,840
+212% +$599K
BSX icon
216
Boston Scientific
BSX
$68.4B
$836K 0.01%
47,243
+1,186
+3% +$21.2K
ZSPH
217
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
$805K 0.01%
15,366
-89
-0.6% -$4.38K
NMBL
218
DELISTED
Nimble Storage, Inc.
NMBL
$797K 0.01%
28,410
-7,028
-20% -$183K
QSR icon
219
Restaurant Brands International
QSR
$26.2B
$784K 0.01%
20,522
-125,745
-86% -$4.96M
RAD
220
DELISTED
Rite Aid Corporation
RAD
$750K 0.01%
4,490
-22
-0.5% -$3.69K
GFN
221
DELISTED
General Finance Corporation
GFN
$724K 0.01%
138,761
-167,919
-55% -$1.12M
IMUX icon
222
Immunic
IMUX
$178M
$692K 0.01%
82
-3
-4% -$28.6K
SBUX icon
223
Starbucks
SBUX
$119B
$630K 0.01%
11,750
+5,730
+95% +$291K
HAIN icon
224
Hain Celestial
HAIN
$44.6M
$591K 0.01%
8,971
-245
-3% -$15.5K
NWHM
225
DELISTED
THE NEW HOME COMPANY INC.
NWHM
$591K 0.01%
34,314
-198
-0.6% -$3.12K

Similar funds

Gilder Gagnon Howe & Co's Q2 2015 Portfolio in Review

As of Q2 2015, Gilder Gagnon Howe & Co held 318 positions worth $7.61B, up 5.8% from $7.2B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Gilder Gagnon Howe & Co's Q2 2015 filing shows 52 new, 54 increased, 160 reduced and 42 closed positions. Its largest new stake was EPAM Systems: 1,551,458 shares worth $111M. The largest sale was KEURIG GREEN MTN INC, an estimated $154M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Gilder Gagnon Howe & Co's largest Q2 2015 buy was EPAM Systems: 1,551,458 shares worth $111M.
  • Gilder Gagnon Howe & Co added most to Illumina in Q2 2015, an estimated $59.2M increase.
  • Gilder Gagnon Howe & Co's biggest Q2 2015 reduction was Yelp, cutting an estimated $53.3M.
  • Gilder Gagnon Howe & Co fully exited KEURIG GREEN MTN INC in Q2 2015, selling an estimated $154M.
  • Gilder Gagnon Howe & Co's ten largest holdings make up 35% of its $7.61B portfolio in Q2 2015.
  • Gilder Gagnon Howe & Co opened 52 new positions and closed 42 in Q2 2015.
  • Gilder Gagnon Howe & Co's portfolio value rose 5.8% quarter-over-quarter to $7.61B.

Based on Gilder Gagnon Howe & Co's 13F filing for Q2 2015, filed 30 Jul 2015.